Literature DB >> 16224485

Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib.

J M Cayuela, P Rousselot, F Nicolini, D Espinouse, C Ollagnier, M H Bui-Thi, K Chabane, E Raffoux, E Callet-Bauchu, I Tigaud, J P Magaud, S Hayette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16224485     DOI： 10.1038/sj.leu.2403986

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report.

Authors:  Michele Massimino; Stefania Stella; Elena Tirrò; Maria Letizia Consoli; Maria Stella Pennisi; Adriana Puma; Silvia Rita Vitale; Chiara Romano; Valentina Zammit; Fabio Stagno; Francesco Di Raimondo; Livia Manzella
Journal:  Oncol Lett       Date:  2019-07-04       Impact factor: 2.967

2.  A Novel e8a2BCR-ABL1 Fusion Transcript without Insertion Sequence in a Patient with Chronic Myeloid Leukemia.

Authors:  Caibao Jin; Xiaojian Zhu; Min Xiao; Songya Liu; Xian Liu; Jingjing Liu; Xiuwen Xu; Shujuan Yi; Li Meng
Journal:  Ann Lab Med       Date:  2018-03       Impact factor: 3.464

3.  A case report of pediatric acute lymphoblastic leukemia with e8a2 BCR/ABL1 fusion transcript.

Authors:  Aleksandra Mroczkowska; Bożena Jaźwiec; Justyna Urbańska-Rakus; Sylwia Szymanowska; Anna Tessmann; Sonia Pająk; Katarzyna Machnik; Olga Haus; Tomasz Wróbel
Journal:  BMC Med Genomics       Date:  2022-02-05       Impact factor: 3.063
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.